BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 28373833)

  • 21. Reciprocal remodeling upon binding of the prion protein to its signaling partner hop/STI1.
    Romano SA; Cordeiro Y; Lima LM; Lopes MH; Silva JL; Foguel D; Linden R
    FASEB J; 2009 Dec; 23(12):4308-16. PubMed ID: 19703931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prion protein in neuroimmune crosstalk.
    Salvesen Ø; Tatzelt J; Tranulis MA
    Neurochem Int; 2019 Nov; 130():104335. PubMed ID: 30448564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological role of the cellular prion protein.
    Zomosa-Signoret V; Arnaud JD; Fontes P; Alvarez-Martinez MT; Liautard JP
    Vet Res; 2008; 39(4):9. PubMed ID: 18073096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cellular and pathologic prion protein.
    Gill AC; Castle AR
    Handb Clin Neurol; 2018; 153():21-44. PubMed ID: 29887138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
    Sarnataro D
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell Biology of Prion Protein.
    Sarnataro D; Pepe A; Zurzolo C
    Prog Mol Biol Transl Sci; 2017; 150():57-82. PubMed ID: 28838675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases.
    Hirsch TZ; Martin-Lannerée S; Reine F; Hernandez-Rapp J; Herzog L; Dron M; Privat N; Passet B; Halliez S; Villa-Diaz A; Lacroux C; Klein V; Haïk S; Andréoletti O; Torres JM; Vilotte JL; Béringue V; Mouillet-Richard S
    Mol Neurobiol; 2019 Mar; 56(3):2159-2173. PubMed ID: 29998397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of ligand-specific PrP (C) signaling in human neuronal cells.
    Arsenault RJ; Li Y; Potter A; Griebel PJ; Kusalik A; Napper S
    Prion; 2012; 6(5):477-88. PubMed ID: 22918447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
    Eraña H; Venegas V; Moreno J; Castilla J
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of proteomics in understanding prion infection.
    Campisi E; Cardone F; Graziano S; Galeno R; Pocchiari M
    Expert Rev Proteomics; 2012 Dec; 9(6):649-66. PubMed ID: 23256675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into cellular prion protein (PrPc) functions: the "ying and yang" of a relevant protein.
    Nicolas O; Gavín R; del Río JA
    Brain Res Rev; 2009 Oct; 61(2):170-84. PubMed ID: 19523487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PrP knock-out and PrP transgenic mice in prion research.
    Weissmann C; Flechsig E
    Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.
    Toni M; Massimino ML; De Mario A; Angiulli E; Spisni E
    Front Neurosci; 2017; 11():3. PubMed ID: 28154522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural Consequences of Copper Binding to the Prion Protein.
    Salzano G; Giachin G; Legname G
    Cells; 2019 Jul; 8(8):. PubMed ID: 31349611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rdj2, a J protein family member, interacts with cellular prion PrP(C).
    Beck KE; Kay JG; Braun JE
    Biochem Biophys Res Commun; 2006 Aug; 346(3):866-71. PubMed ID: 16774738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fate of PrP GPI-anchor signal peptide is modulated by P238S pathogenic mutation.
    Guizzunti G; Zurzolo C
    Traffic; 2014 Jan; 15(1):78-93. PubMed ID: 24112521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease.
    Beckman D; Linden R
    Prion; 2016 Mar; 10(2):131-42. PubMed ID: 27057694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.